Cognate BioServices was a CDMO specializing in cell and gene therapy, offering services such as cGMP cell therapy manufacturing, plasmid DNA production, and solutions for regenerative medicine and immuno-oncology. Their expertise supported the development of advanced therapies in innovative fields. Headquartered in Memphis, Tennessee, Cognate was acquired by Charles River Laboratories in 2021, forming a comprehensive solution for cell and gene therapy development, testing, and manufacturing.

Logo out of use